What’s Next in MBC? Insights from ASCO Annual Meeting 2026
What were some of the biggest metastatic breast cancer updates from the 2026 ASCO Annual Meeting and which findings are already changing care?
In this episode of OUR MBC Life, Dr. Chen breaks down key research findings and what they mean for people living with metastatic breast cancer. This episode also includes a Q & A featuring questions from our community about treatment, side effects and what these new advances mean for people living with metastatic breast cancer.
Meet the Guest of the Episode
Nan Chen, MD
Dr. Chen is an oncologist who specializes in comprehensive breast cancer care. Her practice primarily focuses on treating patients with all forms of breast cancer. She has particular expertise in high-risk and metastatic breast cancer. Dr. Chen offers both standard of care and novel therapies through clinical trials in order to create individualized treatment plans for her patients.
Dr. Chen’s research interests include identifying innovative treatments for both early and advanced breast cancer in addition to identifying new biomarkers to predict response to the therapies. She is very active in clinical research, managing several trials evaluating advanced care for breast cancer. Working closely with laboratory-based researchers at the University of Chicago, Dr. Chen is developing tools that investigate mechanisms of treatment response or resistance.
